克劳丁18在胆管癌中的免疫组织化学作用
Niyati Desai1, Huaibin M Ko1, Michael Lee1
1Department of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, NY, USA.
Journal of gastrointestinal oncology
|May 19, 2025
概括
克劳丁18.2 (CLDN18.2) 在一些胆道癌症中表达,这表明了潜在的治疗选择. 这项研究在13.33%的胆管癌中发现了CLDN18.2表达,使他们有资格接受向治疗.
科学领域:
- 在瘤学瘤学.
- 胃肠病学 胃肠病学
- 免疫治疗是一种免疫疗法.
背景情况:
- 克劳丁 (CLDN) 18.2是晚期胃和食道腺癌的标.
- 针对CLDN18.2的单克隆抗体显示出临床疗效,并已获得FDA对特定患者群体的批准.
- 胆管癌 (CCA) 与胃腺癌有相似之处,但治疗选择有限.
研究的目的:
- 为了研究CLDN18.2在初级胆道瘤中的表达.
- 为了比较CCA中的CLDN18.2表达水平与反CLDN18.2治疗的胃/食道瘤中的表达水平.
主要方法:
- 分析了41个肝内,36个内和28个远端CCA的组织微阵列.
- 使用针对CLDN18的单克隆抗体进行了免疫组织化学检查.
- 高表达被定义为至少75%的瘤细胞中中度到强烈的强度.
主要成果:
- 高CLDN18.2表达在14.63%的肝内,8.3%的状和17.8%的远端CCA中被观察到.
- 总体而言,所有评估的CCA中有13.33%符合高CLDN18.2表达的标准.
- 这种表达水平与适合抗CLDN18.2治疗的胃/食道瘤中的表达水平相当.
结论:
- 胆管癌的一个子集表现出CLDN18.2表达.
- 针对性治疗,如抗CLDN18.2抑制剂可能是高CLDN18.2表达CCA的患者可行的选择.
- 在高表达的CCA患者中研究CLDN18.2抑制剂的临床试验是有必要的.
相关概念视频
01:27Cytotoxic T Cells-mediated Immune Response
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.